Antibiotics: n.e.c. in heading no. 2941

In 2024, antibiotics: n.e.c. in heading no. 2941 trade exhibited modest growth, with global flows reaching $7,465,171,348 and a three-year compound annual growth rate of +2.5% (five-year: -1.6%). The all-time peak of $13,234,981,434 was recorded in 2011; the current level is 44% below that high-water mark.

Over the 30-year observation window (1995–2024), 69% of years recorded positive growth, indicating a predominantly expanding market. Trend momentum is strengthening (+3.2% acceleration).

The World Trade Flows Characterization classifies antibiotics: n.e.c. in heading no. 2941 as "One-way trade" in the unclassified price segment, providing additional context for market positioning and competitive dynamics.

The supply side is moderately concentrated (Herfindahl-Hirschman Index 0.172). The three largest exporters — China ($2.6B), United States ($812.6M), and Switzerland ($810.4M) — collectively dominate supply flows. The leading exporter has grown at +3.3% over the last three years.

On the demand side, importer concentration is diversified (HHI 0.055). The three largest import markets are Italy ($1.0B), India ($883.6M), and United States ($504.6M). The largest importing market sources from 36 different supplying countries.

Estimated substitution elasticity: -7.73. Buyers are highly price-sensitive and can switch between suppliers relatively easily.

The dominant trade corridor is China → India at $744.4M, representing 84.2% of the importer's total demand.

The volatility score for antibiotics: n.e.c. in heading no. 2941 is 2 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, modest but steady demand provides a reasonable entry window. A moderately concentrated market rewards differentiated positioning and strategic partner selection.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.